Category Archives: Announcements

Phagenesis Receives FDA Breakthrough Device Designation For Its Phagenyx® System To Accelerate Removal Of The Breathing Tube By Treating Neurogenic Dysphagia

January 2020

FDA’s Breakthrough Device Designation Program allows for priority review of the Phagenyx® System Manchester, England, 14 January 2020 – Phagenesis Ltd., a pioneering leader in the treatment of dysphagia, is pleased to announce today that the company has received Breakthrough … Continue reading

Promising results of Phagenyx® treatment in Orally Intubated ICU Patients with Dysphagia

July 2019

Post extubation dysphagia is common (44-56%)1 and comes with a lot of challenges. It can impact negatively the patient outcomes by causing aspiration pneumonia and delaying the switch to oral feeding. The duration of mechanical ventilation is independently associated with post-extubation … Continue reading